Hepatitis C - Class Actions Settlement
HomeSearchContact UsFrançaisPrivacy

Essential Information
Additional Information
Loss of Income / Loss of Support / Loss of Services
Periodic Re-Assessment by the Courts
Contacts and Links
Annual Reports

2002 Annual Report

Important Notice!

At the end of Year Two, Annual Reports and Schedules were submitted by all Court appointed service providers and reviewed by the Courts having jurisdiction over the 1986-1990 Hepatitis C Settlement Agreement. This section of the web site includes all Annual Reports and Schedules. Please note that some Schedules have been modified because the original version contains commercially confidential information.

I. Year 2 (for the period ending March 31, 2002) Annual Report of the Joint Committee (Schedule A)
  Overview and Summary
Deloitte & Touche
Schedule B
Schedule C
Schedule D
Schedule E
Schedule F
Schedule G
Schedule H
Royal Trust
Schedule I
TD Asset Management
    Schedule J
Towers Perrin
    Schedule K
Schedule L
Eckler Partners Ltd.
    Schedule M
Price Waterhouse Coopers
Schedule N
Schedule N1
Canadian Blood Services

Schedule O

Appendix 1

Appendix 2
Appendix 3
Appendix 4
Appendix 5

Crawford/Garden City Group Canada
Schedule P
Schedule Q
Fund Counsel
    Schedule R
Joint Committee

Schedule S
Schedule T


Referees and Arbitrators

Schedule U
Schedule U1


II. Financial Statements Prepared by the Court Appointed Auditors - Deloitte & Touche

Auditors' Report for Year 2
Schedule B – Financial Statements
Schedule B - Expenses and Revenue Statements
Notes to the Financial Statements

III. Canadian Blood Services Expenses for Year 2
  Auditors' Notes to the Joint Committee of the 1986 - 1990 Hepatitis C Fund
Schedule E – Appendix For the One-Year Period Ended March 31, 2002

IV. Héma Québec Expenses for Year 2

  Auditors' Notes to the Joint Committee of the 1986 - 1990 Hepatitis C Fund
Schedule F – Appendix For the Period up to March 31, 2002

V. The Administrator's Expenses and Annual Report for Year 2


Claims Activity Operational Highlights
Auditors' Notes to the Joint Committee of the 1986-1990 Hepatitis C Fund